Remarkably, animals lacking hepatic CB1 do not develop dyslipidemia, insulin/leptin resistance, or steatosis when exposed to a high-fat diet (HFD) (Wang et al., 2021). This evidence concerns the gene CNR1 and metabolic syndrome.